EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY-NC 3.0

Emerging Predictive Biomarkers of Immunotherapy Sensitivity in Patients with Non-Small Cell Lung Cancer

Eleonora Gariazzo iD, Francesca Colamartini, Martina Ubaldi, Valentina Santo, Leonardo Brunetti, Chiara Tomarelli, Daniele Ognissanti iD, Jouana Nassar, Silvia Costabile, Luca Romano, Emanuela De Vita, Ilenia Scorpiniti und 6 weitere

ImmunoTargets and Therapy · 2026-02 · Volume 15 · 1-20

DOI: 10.2147/itt.s567238 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift ImmunoTargets and Therapy, 2026-02. Verfasst von Eleonora Gariazzo und 17 weiteren Autor:innen. Beteiligte Einrichtung: Medical Oncology, Santa Maria Della Misericordia Hospital, University of Perugia, Perugia, Italy. Die Arbeit wurde bisher 8-mal zitiert (Crossref) und nennt 158 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 3.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

In recent years, the therapeutic landscape of non-small cell lung cancer (NSCLC) has been transformed by immune checkpoint inhibitors (ICIs), which have led - in some patients - to unprecedented survival expectancy. Nevertheless, identifying patients most likely to benefit from ICI remains a major challenge. While PD-L1 expression and tumor mutation burden (TMB) represent established predictive biomarkers, their predictive ability still needs to be improved, which underscores the need for identifying additional (bio)markers for treatment selection. Recent research has highlighted multiple emerging biomarkers, including genomic alterations (eg, KEAP1, STK11, SMARCA4), markers of metabolic pathway dysregulation (IDO, adenosine axis), tumor-infiltrating lymphocytes, and blood-based biomarkers (eg soluble markers of inflammation, germline HLA diversity, and circulating tumor DNA). Host-related determinants, such as the history of tobacco exposure and the body mass index, further contribute to immunotherapy outcomes. In addition, artificial intelligence (AI) and machine learning (ML) approaches are enabling integration of multidimensional data, leading to predictive scoring systems which have outperformed conventional biomarkers in certain settings. This review synthesizes current evidence on established and emerging predictive biomarkers in NSCLC, highlighting the potential of combining biological, host, and computational features to inform precision immunotherapy strategies.

Schlagwörter

Stichwörter der Autor:innen

NSCLCartificial intelligencehost factorsimmunotherapypredictive biomarkerstumor microenvironment

Autor:innen und Institutionen

  • Medical Oncology, Santa Maria Della Misericordia Hospital, University of Perugia, Perugia, Italy.
  • Lowe Center for Thoracic Oncology, Dana Farber Cancer Institute, Harvard Medical School, Boston, MA, USA.
  • Operative Research Unit of Medical Oncology, Fondazione Policlinico Universitario Campus Bio-Medico, Rome, Italy.
  • Department of Medicine and Surgery, Università Campus Bio-Medico, Rome, Italy.
  • Department of Surgery and Cancer, Hammersmith Hospital Campus, Imperial College London, London, UK.
  • Medical Oncology, Santa Maria della Misericordia Hospital, Perugia, Italy.

ORCID-Profile: Eleonora Gariazzo, Daniele Ognissanti, Miriam Macrì

Zitieren

APA

Gariazzo, E., Colamartini, F., Ubaldi, M., Santo, V., Brunetti, L., Tomarelli, C., Ognissanti, D., Nassar, J., Costabile, S., Romano, L., De Vita, E., Scorpiniti, I., Macrì, M., Porreca, R., Currà, M. F., Cortellini, A., Ricciuti, B., & Metro, G. (2026). Emerging Predictive Biomarkers of Immunotherapy Sensitivity in Patients with Non-Small Cell Lung Cancer. ImmunoTargets and Therapy, Volume 15, 1-20. https://doi.org/10.2147/itt.s567238

Vancouver

Gariazzo E, Colamartini F, Ubaldi M, Santo V, Brunetti L, Tomarelli C, et al. Emerging Predictive Biomarkers of Immunotherapy Sensitivity in Patients with Non-Small Cell Lung Cancer. ImmunoTargets and Therapy. 2026;Volume 15:1-20. doi:10.2147/itt.s567238

BibTeX
@article{Gariazzo2026,
  author = {Gariazzo, Eleonora and Colamartini, Francesca and Ubaldi, Martina and Santo, Valentina and Brunetti, Leonardo and Tomarelli, Chiara and Ognissanti, Daniele and Nassar, Jouana and Costabile, Silvia and Romano, Luca and De Vita, Emanuela and Scorpiniti, Ilenia and Macrì, Miriam and Porreca, Roberta and Currà, Maria Francesca and Cortellini, Alessio and Ricciuti, Biagio and Metro, Giulio},
  title = {Emerging Predictive Biomarkers of Immunotherapy Sensitivity in Patients with Non-Small Cell Lung Cancer},
  journal = {ImmunoTargets and Therapy},
  year = {2026},
  volume = {Volume 15},
  pages = {1--20},
  doi = {10.2147/itt.s567238}
}
Kostenlos starten →